G. Deye

发表

Identification of Acinetobacter Species and Genotyping of Acinetobacter baumannii by Multilocus PCR and Mass Spectrometry

D. Ecker, R. Sampath, T. Hall, 2006, Journal of Clinical Microbiology.

The metabolism of primaquine to its active metabolite is dependent on CYP 2D6

D. Caridha, L. Walker, C. Ockenhouse, 2013, Malaria Journal.

Comparison of Acinetobacter baumannii Isolates from the United Kingdom and the United States That Were Associated with Repatriated Casualties of the Iraq Conflict

M. Kaufmann, T. Pitt, J. Turton, 2006, Journal of Clinical Microbiology.

PfSPZ-CVac efficacy against malaria increases from 0% to 75% when administered in the absence of erythrocyte stage parasitemia: A randomized, placebo-controlled trial with controlled human malaria infection

S. Hoffman, J. Kublin, T. Richie, 2021, PLoS pathogens.

An outbreak of Plasmodium falciparum malaria in U.S. Marines deployed to Liberia.

Christopher D. Clagett, D. Freilich, W. Milhous, 2010, The American journal of tropical medicine and hygiene.

Randomized controlled trial of trimethoprim-sulfamethoxazole for uncomplicated skin abscesses in patients at risk for community-associated methicillin-resistant Staphylococcus aureus infection.

M. Mete, G. Schmitz, T. Livengood, 2010, Annals of emergency medicine.

Tafenoquine and NPC-1161B require CYP 2D metabolism for anti-malarial activity: implications for the 8-aminoquinoline class of anti-malarial compounds

D. Caridha, L. Walker, Q. Zeng, 2014, Malaria Journal.

Baricitinib plus Remdesivir for Hospitalized Adults with Covid-19

Cameron R. Wolfe, A. Amin, M. Proschan, 2020, The New England journal of medicine.

Efficacy of interferon beta-1a plus remdesivir compared with remdesivir alone in hospitalised adults with COVID-19: a double-blind, randomised, placebo-controlled, phase 3 trial

Michael R. Wierzbicki, Tom M. Conrad, Cameron R. Wolfe, 2021, The Lancet Respiratory Medicine.

Acinetobacter baumannii infections among patients at military medical facilities treating injured U.S. service members, 2002-2004.

J. Malone, K. Petersen, L. Lindler, 2004, MMWR. Morbidity and mortality weekly report.

A genetically engineered Plasmodium falciparum parasite vaccine provides protection from controlled human malaria infection

J. Kublin, A. Vaughan, S. Kappe, 2022, Science Translational Medicine.

PfSPZ-CVac malaria vaccine demonstrates safety among malaria-experienced adults: A randomized, controlled phase 1 trial

G. E. Potter, S. Hoffman, O. Doumbo, 2022, EClinicalMedicine.

Dose dependent infectivity of aseptic, purified, cryopreserved Plasmodium falciparum 7G8 sporozoites in malaria-naive adults.

G. E. Potter, Andrea A. Berry, S. Hoffman, 2019, The Journal of infectious diseases.

Phase Ib Trial To Evaluate the Safety and Pharmacokinetics of Multiple Ascending Doses of Filociclovir (MBX-400, Cyclopropavir) in Healthy Volunteers

M. Mulligan, N. Rouphael, S. Hurwitz, 2019, Antimicrobial Agents and Chemotherapy.

Pharmacokinetics, Safety, and Tolerability of Oxfendazole in Healthy Adults in an Open-Label Phase 1 Multiple Ascending Dose and Food Effect Study

R. Gilman, H. García, Armando E Gonzalez, 2020, Antimicrobial Agents and Chemotherapy.

Baricitinib versus dexamethasone for adults hospitalised with COVID-19 (ACTT-4): a randomised, double-blind, double placebo-controlled trial

Catharine I Paules, R. Hyzy, M. Proschan, 2022, The Lancet Respiratory Medicine.

Low dose recombinant full-length circumsporozoite protein-based Plasmodium falciparum vaccine is well-tolerated and highly immunogenic in phase 1 first-in-human clinical testing.

M. Travassos, Effie Y. H. Nomicos, M. Laurens, 2021, Vaccine.

An outbreak of multidrug-resistant Acinetobacter baumannii-calcoaceticus complex infection in the US military health care system associated with military operations in Iraq.

J. Patel, C. Murray, K. Petersen, 2007, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Primaquine for prophylaxis of malaria: has the CYP sailed?

A. Magill, G. Deye, 2014, Journal of travel medicine.

Prolonged protection provided by a single dose of atovaquone-proguanil for the chemoprophylaxis of Plasmodium falciparum malaria in a human challenge model.

J. Dumler, A. Magill, Bryan L. Smith, 2012, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Population Pharmacokinetic-Pharmacodynamic Model of Oxfendazole in Healthy Adults in a Multiple Ascending Dose and Food Effect Study and Target Attainment Analysis

P. Winokur, J. Horton, G. An, 2021, Antimicrobial agents and chemotherapy.

Population Pharmacokinetic Model of Oxfendazole and Metabolites in Healthy Adults following Single Ascending Doses

L. Stebounova, D. Murry, P. Winokur, 2021, Antimicrobial Agents and Chemotherapy.

Pharmacokinetics, Safety, and Tolerability of Oxfendazole in Healthy Volunteers: a Randomized, Placebo-Controlled First-in-Human Single-Dose Escalation Study

D. Ince, R. Gilman, L. Stebounova, 2019, Antimicrobial Agents and Chemotherapy.

Pharmacokinetics , Safety , and Tolerability of Oxfendazole in 1 Healthy Volunteers : a Randomized , Placebo-Controlled First-in-2 Human Single-Dose Escalation Study

R. Gilman, Dilek, H. García, 2019 .

The metabolism of primaquine to its active metabolite is dependent on CYP 2D6

D. Caridha, L. Walker, C. Ockenhouse, 2013, Malaria Journal.

Use of a rhesus Plasmodium cynomolgi model to screen for anti-hypnozoite activity of pharmaceutical substances.

A. Magill, J. Sattabongkot, C. Ohrt, 2012, The American journal of tropical medicine and hygiene.

EVITA Dengue: a cluster-randomized controlled trial to EValuate the efficacy of Wolbachia-InfecTed Aedes aegypti mosquitoes in reducing the incidence of Arboviral infection in Brazil

G. E. Potter, D. Cummings, A. Ko, 2022, Trials.

Temporal Improvements in COVID-19 Outcomes for Hospitalized Adults: A Post Hoc Observational Study of Remdesivir Group Participants in the Adaptive COVID-19 Treatment Trial

Cameron R. Wolfe, G. E. Potter, R. Davey, 2022, Annals of Internal Medicine.

Primaquine failure and cytochrome P-450 2D6 in Plasmodium vivax malaria.

W. Mccarthy, C. Ockenhouse, J. Bennett, 2013, The New England journal of medicine.

Plasmodium falciparum infection during suppressive prophylaxis with mefloquine does not induce an antibody response to merozoite surface protein-1(42).

A. Magill, J. Moon, R. Miller, 2011, The American journal of tropical medicine and hygiene.

Case-control study of armadillo contact and Hansen's disease.

C. Murray, G. Deye, L. Horvath, 2006, The American journal of tropical medicine and hygiene.

A randomized, controlled Phase 1b trial of the Sm-TSP-2 Vaccine for intestinal schistosomiasis in healthy Brazilian adults living in an endemic area

P. Hotez, W. Keitel, Shital M. Patel, 2023, PLoS neglected tropical diseases.

A phase 1 study of the safety, reactogenicity, and immunogenicity of a Schistosoma mansoni vaccine with or without glucopyranosyl lipid A aqueous formulation (GLA-AF) in healthy adults from a non-endemic area.

G. E. Potter, P. Hotez, W. Keitel, 2019, Vaccine.

Pertussis Outbreak in a US Military Community: Kaiserslautern, Germany, April—June 2005

W. Aldous, G. Deye, J. Mancuso, 2007 .

Emergent 2009 influenza A(H1N1) viruses containing HA D222N mutation associated with severe clinical outcomes in the Americas.

P. Blair, Jose L. Sanchez, Eric S. Halsey, 2012, Journal of clinical virology : the official publication of the Pan American Society for Clinical Virology.

A case of Leuconostoc ventriculitis with resistance to carbapenem antibiotics.

J. Jorgensen, J. Patterson, G. Deye, 2003, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Adverse Reactions in a Phase 1 Trial of the Anti-Malarial DM1157: An Example of Pharmacokinetic Modeling and Simulation Guiding Clinical Trial Decisions

M. Cohen-Wolkowiez, R. Randell, S. Balevic, 2022, Infectious Diseases and Therapy.

Methicillin resistant Staphylococcus Aureus (MRSA) endocarditis secondary to tongue piercing.

M. Yerkey, G. Deye, Peter Harding, 2002, Journal of the Mississippi State Medical Association.

Baricitinib plus Remdesivir for Hospitalized Adults with Covid-19

Cameron R. Wolfe, A. Amin, M. Proschan, 2020, New England Journal of Medicine.